Alpha II-Spectrin Breakdown Products Serve as Novel Markers of Brain Injury Severity in a Canine Model of Hypothermic Circulatory Arrest

Annals of Thoracic Surgery

Volumn 88, Issue 2, 2009, Pages 543-550

  Weiss, Eric S ^a   Wang, Kevin K W ^c   Allen, Jeremiah G ^a   Blue, Mary E ^a,b   Nwakanma, Lois U ^a   Liu, Ming Cheng ^c   Lange, Mary S ^b   Berrong, Jennifer ^b   Wilson, Mary Ann ^a,b   Gott, Vincent L ^a   Troncoso, Juan C ^a   Hayes, Ronald L ^c   Johnston, Michael V ^a,b   Baumgartner, William A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALPAIN; CASPASE 3; FODRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BASAL GANGLION; BRAIN INJURY; CARDIOPULMONARY BYPASS; CELL DEATH; CEREBELLUM; CLINICAL INDICATOR; CONTROLLED STUDY; DENSITOMETRY; DIAGNOSTIC VALUE; DISEASE MARKER; EXPERIMENTAL DOG; HEART ARREST; HIPPOCAMPUS; HISTOPATHOLOGY; HYPOTHERMIA; IMMUNOBLOTTING; INJURY SEVERITY; MALE; NONHUMAN; PARIETAL LOBE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN ISOLATION; SCORING SYSTEM; TYMPANIC TEMPERATURE;

ANIMALS; APOPTOSIS; BASAL GANGLIA; BIOLOGICAL MARKERS; BRAIN INJURIES; CALPAIN; CASPASES; CEREBELLUM; DENTATE GYRUS; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEART ARREST, INDUCED; HYPOTHERMIA, INDUCED; IMMUNOBLOTTING; MALE; MODELS, ANIMAL; NECROSIS; PARIETAL LOBE; SPECTRIN;

EID: 67650707926     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.04.016     Document Type: Article

References (28)

1. Redmond J.M., Greene P.S., Goldsborough M.A., et al. Neurologic injury in cardiac surgical patients with a history of stroke. Ann Thorac Surg 61 (1996) 42-47
2. Roach G.W., Kanchuger M., Mangano C.M., et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 335 (1996) 1857-1863
3. Bellinger D.C., Jonas R.A., Rappaport L.A., et al. Developmental and neurologic status of children after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. N Engl J Med 332 (1995) 549-555
4. Hickey P.R. Neurologic sequelae associated with deep hypothermic circulatory arrest. Ann Thorac Surg 65 Suppl (1998) 65-70
5. Unden J., Astrand R., Waterloo K., et al. Clinical significance of serum S100B levels in neurointensive care. Neurocrit Care 6 (2007) 94-99
6. Muley T., Ebert W., Stieber P., et al. Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay. Clin Chem Lab Med 41 (2003) 95-103
7. Laterza O.F., Modur V.R., Crimmins D.L., et al. Identification of novel brain biomarkers. Clin Chem 52 (2006) 1713-1721
8. Pike B.R., Flint J., Dave J.R., et al. Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 24 (2004) 98-106
9. Pike B.R., Flint J., Dutta S., Johnson E., Wang K.K., and Hayes R.L. Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J Neurochem 78 (2001) 1297-1306
10. Goodman S.R., Zimmer W.E., Clark M.B., Zagon I.S., Barker J.E., and Bloom M.L. Brain spectrin: of mice and men. Brain Res Bull 36 (1995) 593-606
11. Riederer B.M., Zagon I.S., and Goodman S.R. Brain spectrin (240/235) and brain spectrin (240/235E): two distinct spectrin subtypes with different locations within mammalian neural cells. J Cell Biol 102 (1986) 2088-2097
12. Wang K.K., Posmantur R., Nath R., et al. Simultaneous degradation of alphaII- and betaII-spectrin by caspase 3 (CPP32) in apoptotic cells. J Biol Chem 273 (1998) 22490-22497
13. Beer R., Franz G., Srinivasan A., et al. Temporal profile and cell subtype distribution of activated caspase-3 following experimental traumatic brain injury. J Neurochem 75 (2000) 1264-1273
14. Hall E.D., Sullivan P.G., Gibson T.R., Pavel K.M., Thompson B.M., and Scheff S.W. Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury. J Neurotrauma 22 (2005) 252-265
15. Cardali S., and Maugeri R. Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury. J Neurosurg Sci 50 (2006) 25-31
16. Pineda J.A., Lewis S.B., Valadka A.B., et al. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J Neurotrauma 24 (2007) 354-366
17. Barreiro C.J., Williams J.A., Fitton T.P., et al. Noninvasive assessment of brain injury in a canine model of hypothermic circulatory arrest using magnetic resonance spectroscopy. Ann Thorac Surg 81 (2006) 1593-1598
18. Redmond J.M., Gillinov A.M., Zehr K.J., et al. Glutamate excitotoxicity: a mechanism of neurologic injury associated with hypothermic circulatory arrest. J Thorac Cardiovasc Surg 107 (1994) 776-787
19. Williams J.A., Barreiro C.J., Nwakanma L.U., et al. Valproic acid prevents brain injury in a canine model of hypothermic circulatory arrest: a promising new approach to neuroprotection during cardiac surgery. Ann Thorac Surg 81 (2006) 2235-2242
20. Shake J.G., Peck E.A., Marban E., et al. Pharmacologically induced preconditioning with diazoxide: a novel approach to brain protection. Ann Thorac Surg 72 (2001) 1849-1854
21. Tisherman S.A., Safar P., Radovsky A., et al. Profound hypothermia (less than 10 degrees C) compared with deep hypothermia (15 degrees C) improves neurologic outcome in dogs after two hours' circulatory arrest induced to enable resuscitative surgery. J Trauma 31 (1991) 1051-1062
22. Ringger N.C., O'Steen B.E., Brabham J.G., et al. A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels. J Neurotrauma 21 (2004) 1443-1456
23. Pike B.R., Zhao X., Newcomb J.K., Glenn C.C., Anderson D.K., and Hayes R.L. Stretch injury causes calpain and caspase-3 activation and necrotic and apoptotic cell death in septo-hippocampal cell cultures. J Neurotrauma 17 (2000) 283-298
24. Dutta S., Chiu Y.C., Probert A.W., and Wang K.K. Selective release of calpain produced alphalI-spectrin (alpha-fodrin) breakdown products by acute neuronal cell death. Biol Chem 383 (2002) 785-791
25. Nath R., Probert A., McGinnis K.M., and Wang K.K. Evidence for activation of caspase-3-like protease in excitotoxin- and hypoxia/hypoglycemia-injured neurons. J Neurochem 71 (1998) 186-195
26. Siman R., McIntosh T.K., Soltesz K.M., Chen Z., Neumar R.W., and Roberts V.L. Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol Dis 16 (2004) 311-320
27. Siman R., Zhang C., Roberts V.L., Pitts-Kiefer A., and Neumar R.W. Novel surrogate markers for acute brain damage: cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat. J Cereb Blood Flow Metab 25 (2005) 1433-1444
28. Siman R., Roberts V.L., McNeil E., et al. Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest. Brain Res 1213 (2008) 1-11